| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,629 |
19,381 |
$818K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
347 |
265 |
$16K |
| 99307 |
|
1,399 |
1,215 |
$15K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,822 |
3,256 |
$12K |
| 87449 |
|
1,332 |
1,097 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
141 |
137 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
2,538 |
2,232 |
$2K |
| 81000 |
|
684 |
577 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
72 |
64 |
$887.54 |
| 82948 |
|
336 |
296 |
$729.64 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,694 |
1,413 |
$587.39 |
| 90688 |
|
241 |
224 |
$571.96 |
| 85027 |
|
106 |
90 |
$373.56 |
| 87807 |
|
41 |
30 |
$341.91 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
32 |
26 |
$152.28 |
| G0008 |
Administration of influenza virus vaccine |
317 |
261 |
$13.06 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
87 |
74 |
$0.00 |